Consolidated Statements of Operations (USD $)	3 Months Ended		163 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013
Operating expenses:
Research and development	$ 2,700	$ 7,150	$ 8,879,177
General and administrative	261,966	273,657	16,261,512
Total operating expenses	264,666	280,807	25,140,689
Operating loss	(264,666)	(280,807)	(25,140,689)
Incentive for early warrant exercise	0	0	(1,999,622)
Incentive for early warrant exercise - related parties	0	0	(727,481)
Interest income	0	0	23,867
Interest expense	(50,303)	(32,912)	(5,762,124)
Interest expense - related parties	(24,664)	(14,473)	(2,431,605)
Debt extinguishment expense	(51,635)	(5,932)	(1,613,961)
Debt extinguishment expense - related parties	(100,576)	(73,554)	(1,761,843)
Net loss	$ (491,844)	$ (407,678)	$ (39,413,458)
Net loss per common share:
Basic and diluted (in dollars per share)	$ (0.03)	$ (0.02)	$ (7.57)
Weighted average number of shares outstanding:
Basic and diluted (in shares)	18,302,350	16,498,859	5,207,869